Clinical Trials Directory

Trials / Completed

CompletedNCT05614635

Safety and Technical Performance of Plastalgin and Plastalgin Fast in Patients Requiring a Dental Impression

Prospective, Multicenter, Observational cLinical triAl Measuring Safety and Technical Performance of plAstalgin and Plastalgin Fast in Patients Requiring a Dental Impression

Status
Completed
Phase
Study type
Observational
Enrollment
59 (actual)
Sponsor
Septodont · Industry
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to gather clinical data related to the use of Plastalgin and Plastalgin Fast, in order to comply with the new medical device regulation. The target population for this study is the same as the intended population specified in the study device's instructions for use: children from 5 years old and adults. Collection, recording, and reporting of data will be accurate and will ensure the privacy, health, and welfare of participating patients during and after the study

Conditions

Interventions

TypeNameDescription
DEVICEPlastalgin and Plastalgin FastPlastalgin and Plastalgin Fast are potassium alginate-based powders designed for dental impression. The powder is mixed with water to obtain an impression material paste, used to imprint the teeth and mouth of the patient. The product is available under two presentations: Plastalgin and Plastalgin Fast. Plastalgin Fast has a shorter mixing time.

Timeline

Start date
2022-10-12
Primary completion
2023-03-07
Completion
2023-03-07
First posted
2022-11-14
Last updated
2023-04-24

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05614635. Inclusion in this directory is not an endorsement.